3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.

Interestingly in the signatures in both pairwise comparisons, PDK1 was a highly significant outlier and upregulation was the highest in the osimertinib-resistant tumors (Fig. 3f , middle; Suppl Fig. 3B ).

also in 132,142 other papers